Vanderbilt awarded up to $46M through ARPA-H to develop tools against alphaviruses
Vanderbilt University will receive up to $46 million in funding from the Advanced Research Projects Agency for Health to spearhead the development of a vaccine that could protect against all alphaviruses.
Jens Meiler, Distinguished Research Professor of Chemistry, was named the principal investigator for the project, in cooperation with 14 investigators across eight institutions. The team will work together to use advanced technology, including computational modeling, AI-driven predictions and structural biology, to develop a groundbreaking vaccine against all alphaviruses that offers long-lasting protection.
Jens Meiler (Photo via Humboldt Foundation/Elbmotion)